ایران دارو

دیران | Stocks - Tehran Stock Exchange (TSE)
داروهای شیمیایی و گیاهی
Sector:

داروهای شیمیایی و گیاهی

Market Type:

Stocks

Status:

Authorized

Last Price: 22,480 2.98
Close Price: 22,480

Financial Ratios

2026/05/20
Fiscal Year 2025/12/2112 Month
2025/04/20
Fiscal Year 2024/12/2012 Month
2024/04/17
Fiscal Year 2023/12/2112 Month

Net Profit to Sales

4.210.317.62

Gross Profit to Sales

8.772.0321.34

Operating Margin

31.6321.4632.61

Gross Profit to Sales

39.4828.2236.76

Net Profit to Gross Profit

10.661.0747.92

Return on Assets (ROA)

3.370.1913.46

Return on Capital (%)

20.420.98105.34

Return on Equity (ROE)

14.390.8341.08

Working Capital Return

9.160.4941.03

Fixed Asset Return

102.317.1570.34

Loan Benefit Assessment

4.274.313.05

Current Ratio

1.621.71.51

Quick Ratio

1.291.431.18

Liquidity Ratio

0.010.020.06

Net Working Capital

3,968,5453,605,1482,259,564

Current Assets Ratio

0.960.970.97

Inventory Turnover

122.96123.67148.09

Receivables Collection Period

301.41430.78332.77

Inventory to Working Capital

0.540.380.64

Working Capital Turnover

2.181.612.33

Fixed Asset Turnover

24.3123.5532.37

Total Asset Turnover

0.80.640.76

Debt Ratio

0.770.770.67

Debt to Equity

3.273.312.05

Long-Term Debt to Equity

0.750.850.08

Current Debt to Equity

2.522.461.97

Equity Ratio

23.4523.2132.77

Debt Coverage Ratio

0.190.140.87